MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
MannKind (Nasdaq: MNKD) announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026.
Rhea-AI Summary
MannKind (Nasdaq: MNKD) announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will host a conference call at 4:30 p.m. Eastern Time, with a live webcast and a replay available via the company’s investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MNKD
In the Jul 29 session, MNKD declined 1.53%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting period
- Second quarter 2026
- Financial results announcement
- Results date
- August 5, 2026
- After market close
- Conference call time
- 4:30 p.m. Eastern Time
- August 5, 2026
- Replay availability
- Within 24 hours
- Following the conference call
- Replay duration
- Approximately 90 days
- Accessible from the company website
Previous Conferences,earnings date Reports
-
Third-quarter results and conference call scheduled for November 5, 2025
-
Second-quarter results and conference call scheduled for August 6, 2025
-
First-quarter results and webcast scheduled for May 8, 2025
-
Fourth-quarter and full-year results scheduled after market close February 26, 2025
-
Third-quarter results and webcast scheduled for November 7, 2024
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that the Company will report second quarter 2026 financial results after market close on Wednesday, August 5, 2026.
MannKind’s management team will host a conference call at 4:30 p.m. Eastern Time to review the financial results and provide a business update.
The webcast of the conference call will be accessible via a link on MannKind’s website at https://investors.mannkindcorp.com/events-and-presentations. A replay will be available in the same location within 24 hours following the call and will be accessible for approximately 90 days.
About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.
Learn more at mannkindcorp.com.

Contacts: Investor Relations Kate Miranda (617) 921-5461 Email: ir@mnkd.com Media Relations Christie Iacangelo (818) 292-3500 Email: media@mnkd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.